insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,44 $
arrow_downward
-3,30%(-0,15) 1D
18 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 $
High
4,60 $
Low
4,41 $
Mkt. cap
61,82 մլն
Avg. vol.
7,41 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,41 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,55 $
High
4,60 $
Low
4,41 $
Mkt. cap
61,82 մլն
Avg. vol.
7,41 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,41 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
17 րոպե առաջ
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Benzinga
·
10 րոպե առաջ
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com